Technology | 2017.05.17
FDA Clears New Indication for Myoscience’s iovera° System to Relieve Pain and Symptoms Associated with Osteoarthritis of the Knee
California-based Myoscience, Inc. announced that the U.S. Food & Drug Administration (FDA) has cleared its ioveraº device for the relief of pain and symptoms associated with osteoarthritis of the knee for up to 90 days. The ioveraº technology is a non-opioid and non-systemic treatment for blocking pain signals from peripheral nerves.
(PRWeb May 17, 2017)
Read the full story at http://www.prweb.com/releases/2017/05/prweb14344185.htm
For more information, please visit
http://www.prweb.com/releases/2017/05/prweb14344185.htm
